Vascular endothelial growth factor in primate endometrium is regulated by oestrogen-receptor and progesterone-receptor ligands in vivo
Authors:
- G. D. HodgenGHG. D. Hodgen
Open Access
- 1 June 1997
- journal article
- research article
- Published by Oxford University Press (OUP) in Human Reproduction
- Vol. 12 (6) , 1280-1292
Abstract
We investigated hormonal regulation of endometrial angiogenesis in menstruating primates. This study was designed to demonstrate: (i) that cell-specific vascular endothelial growth factor (VEGF) production and expression in monkey endometrium are regulated by steroid receptor ligands; and (ii) mifepristone (RU 486) alters VEGF production even in the absence of a progestin agonist. Endometrial VEGF production was compared by computer-assisted immunohistochemical analysis during induced hypoestrogenism and after oestradiol, progestin, or antiprogestin (mifepristone) treatment. VEGF gene expression was estimated by quantitative reverse-transcriptase polymerase chain reaction (RT-PCR) in endometrial samples from castrate cynomolgus monkeys, from intact monkeys in the luteal phase, and from monkeys treated for 20 days with levonorgestrel (LNG) or mifepristone. VEGF staining intensities in glandular epithelium and VEGF mRNA expression were highest in hypoestrogenic monkeys. Progestin treatment induced intense VEGF staining in the stroma. Gene expression of VEGF-189, but not other isoforms, was higher in progesterone- and progestin (LNG)-exposed endometria compared to mifepristone-exposed endometria or endometria from anovulatory cycles (P < 0.04). Mifepristone abolished VEGF staining in glandular epithelium almost completely. We conclude that VEGF protein and VEGF mRNA expression levels in primate endometrium depend on the steroidal milieu. Anti-angiogenic effects of mifepristone via suppression of VEGF production might represent a mechanism for its quelling effects on endometrium.Keywords
This publication has 14 references indexed in Scilit:
- Oestrogen action in the endometrium and oviduct of rhesus monkeys during RU486 treatmentHuman Reproduction, 1994
- Angiostatin: A Circulating Endothelial Cell Inhibitor That Suppresses Angiogenesis and Tumor GrowthCold Spring Harbor Symposia on Quantitative Biology, 1994
- The vascular endothelial growth factor (VEGF) isoforms: differential deposition into the subepithelial extracellular matrix and bioactivity of extracellular matrix-bound VEGF.Molecular Biology of the Cell, 1993
- Contraception: Endometrial microvascular density during the normal menstrual cycle and following exposure to long-term levonorgestrelHuman Reproduction, 1993
- Vascular permeability factor (VPF, VEGF) in tumor biologyCancer and Metastasis Reviews, 1993
- Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivoNature, 1992
- Endothelial cell migratory signal produced by human endometrium during the menstrual cycleHuman Reproduction, 1992
- Vascular endothelial growth factor (VEGF) induces plasminogen activators and plasminogen activator inhibitor-1 in microvascular endothelial cellsBiochemical and Biophysical Research Communications, 1991
- Regulation of the activity of a new inhibitor of angiogenesis by a cancer suppressor geneCell, 1989
- Evolutionary conservation in the untranslated regions of actin mRNAs: DNA sequence of a human beta-actin cDNANucleic Acids Research, 1984